“…By resembling tissue–tissue interfaces, physicochemical microenvironments, and vascular irrigation of the body, these devices produce levels of tissue and organ functionality not possible with conventional 2D or 3D culture systems while also enabling high‐resolution, real‐time imaging, and in vitro analysis of biochemical, genetic, and metabolic activities of living cells in a functional tissue and organ context (Mosier, Peters, Larsen, & Cady, ). Given that organ‐on‐chip methods have already proven useful for the study of multiple organ systems (Alexander, Eggert, & Wiest, ; Caballero et al., ; Esch, Bahinski, & Huh, ; Escutia‐Guadarrama et al., ; Kodzius, Schulze, Gao, & Schneider, ; Mosig, ; Van der Helm, van der Meer, Eijkel, van den Berg, & Segerink, ), there is little doubt that this technology shows great potential to advance the study of SG development, physiology, and disease etiology. Moreover, it could be a game changer in the context of drug discovery and development by making possible nearly limitless trials, thereby leading to cheaper and better targeted studies of molecular mechanisms of action, prioritization of lead candidates, toxicity testing, and biomarker identification (Liu, Gill, & Shery Huang, ).…”